Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies. - Schiavetti I; Cordioli C; Stromillo ML; Teresa Ferrò M; Laroni A; Cocco E; Cola G; Pasquali L; Rilla MT; Signoriello E; Iodice R; Di Sapio A; et al. (Multiple sclerosis (Houndmills, Basingstoke, England), 2022)